Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes"

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5110-5111. doi: 10.1210/jc.2019-00851.

Authors

Giulia Sapuppo¹, Martina Tavarelli¹, Antonino Belfiore¹, Riccardo Vigneri^{1

2}, Gabriella Pellegriti³

Affiliations

¹ Endocrinology, Department of Clinical and Experimental Medicine, Garibaldi-Nesima Medical Center, University of Catania, Catania, Italy.
² Institute of Biostructures and Bioimages, National Research Council, Catania, Italy.
³ Endocrinology, Garibaldi-Nesima Medical Center, Catania, Italy.

PMID: 31127825
DOI: 10.1210/jc.2019-00851

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma*
Cell Differentiation
Humans
Neoplasm Recurrence, Local
Thyroid Neoplasms*